# A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC)

> **NCT01451658** · PHASE4 · UNKNOWN · sponsor: **Taipei Veterans General Hospital, Taiwan** · enrollment: 100 (estimated)

## Conditions studied

- Gastroesophageal Varices Hemorrhage
- Hepatocellular Carcinoma

## Interventions

- **DRUG:** propranolol

## Key facts

- **NCT ID:** NCT01451658
- **Lead sponsor:** Taipei Veterans General Hospital, Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-12
- **Primary completion:** 2020-07-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01451658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01451658, "A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01451658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*